SPY331.78+1.72 0.52%
DIA271.30+2.89 1.08%
IXIC10,975.61+34.45 0.31%

B. Riley Maintains Buy on OptimizeRx, Lowers Price Target to $21

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $26 to $21.

Benzinga · -

B. Riley maintains OptimizeRx (NASDAQ:OPRX) with a Buy and lowers the price target from $26 to $21.